These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10064113)

  • 1. Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients.
    Brites FD; Cavallero E; de Geitere C; Nicolaïew N; Jacotot B; Rosseneu M; Fruchart JC; Wikinski RL; Castro GR
    Clin Chim Acta; 1999 Jan; 279(1-2):1-14. PubMed ID: 10064113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles.
    Cavallero E; Brites F; Delfly B; Nicolaïew N; Decossin C; De Geitere C; Fruchart JC; Wikinski R; Jacotot B; Castro G
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2130-5. PubMed ID: 7489233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?
    Lecomte E; Herbeth B; Paille F; Steinmetz J; Artur Y; Siest G
    Clin Chem; 1996 Oct; 42(10):1666-75. PubMed ID: 8855152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport.
    Dullaart RP; van Tol A
    Diabet Med; 2001 Jun; 18(6):509-13. PubMed ID: 11472472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial reverse cholesterol transport in type 2 diabetic patients: effect of a lipid lowering treatment.
    Autran D; Attia N; Dedecjus M; Durlach V; Girard-Globa A
    Atherosclerosis; 2000 Dec; 153(2):453-60. PubMed ID: 11164435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal and postprandial serum-promoted cholesterol efflux in normolipidemic subjects: Importance of fat mass distribution.
    Autran D; Guerci B; Paul JL; Moulin P; Vergés B; Durlach V; Girard-Globa A
    Metabolism; 2001 Nov; 50(11):1330-5. PubMed ID: 11699052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment.
    de Vries R; Kerstens MN; Sluiter WJ; Groen AK; van Tol A; Dullaart RP
    Diabetologia; 2005 Jun; 48(6):1105-13. PubMed ID: 15875154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein.
    Syvänne M; Castro G; Dengremont C; De Geitere C; Jauhiainen M; Ehnholm C; Michelagnoli S; Franceschini G; Kahri J; Taskinen MR
    Atherosclerosis; 1996 Dec; 127(2):245-53. PubMed ID: 9125315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis.
    Forte TM; Nichols AV; Krauss RM; Norum RA
    J Clin Invest; 1984 Nov; 74(5):1601-13. PubMed ID: 6501564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease.
    Attia N; Nakbi A; Smaoui M; Chaaba R; Moulin P; Hammami S; Hamda KB; Chanussot F; Hammami M
    Tohoku J Exp Med; 2007 Oct; 213(2):129-37. PubMed ID: 17917406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels.
    Brites FD; Bonavita CD; De Geitere C; Cloës M; Delfly B; Yael MJ; Fruchart J; Wikinski RW; Castro GR
    Atherosclerosis; 2000 Sep; 152(1):181-92. PubMed ID: 10996354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels.
    Rivellese AA; De Natale C; Di Marino L; Patti L; Iovine C; Coppola S; Del Prato S; Riccardi G; Annuzzi G
    J Clin Endocrinol Metab; 2004 May; 89(5):2153-9. PubMed ID: 15126535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial lipid abnormalities in type 2 diabetes mellitus.
    Madhu SV; Mittal V; Ram BK; Srivastava DK
    J Assoc Physicians India; 2005 Dec; 53():1043-6. PubMed ID: 16572960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport.
    El Khoury P; Waldmann E; Huby T; Gall J; Couvert P; Lacorte JM; Chapman J; Frisdal E; Lesnik P; Parhofer KG; Le Goff W; Guerin M
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):285-94. PubMed ID: 26681758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein C subtype distribution in type 2 diabetes mellitus.
    Gomez JA; del Pozo C; Sorribas A; Serrat J; Gonzalez-Sastre F; de Leiva A
    Diabet Med; 1989 Mar; 6(2):127-30. PubMed ID: 2522853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JA; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2002 Oct; 90(7):689-96. PubMed ID: 12356379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo glucosylated LpA-I subfraction. Evidence for structural and functional alterations.
    Igau B; Castro G; Clavey V; Slomianny C; Bresson R; Drouin P; Fruchart JC; Fiévet C
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2830-6. PubMed ID: 9409262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.